Myocarditis clinical trials

Explore recruiting myocarditis clinical trials.

Recruiting myocarditis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Myocarditis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC).

Poland

Therapeutic use (Phase IV) EU CTIS Study details

COTAM - Use of glucocorticoids therapy in acute myocarditis with severe left ventricular dysfunction: a multicenter randomized controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

“Impact of CardiolRx on Myocardial Recovery in patients with Acute Myocarditis. A double-blind, placebo-controlled trial (ARCHER)”

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Pulse corticosteroids or/and Immunoglobulins to treat fulminant Myocarditis: a double-blind randomized controlled adaptive trial (The CORIUM study)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Single-blind, investigator-initiated, randomized, controlled trial to assess the safety and efficacy of intravenous corticosteroid therapy to treat patients with acute myocarditis with mildly reduced left ventricular ejection fraction

Belgium, Italy, Slovenia, Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) versus Conventional Treatment in Acute Myocarditis

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Myocarditis trials by city

Myocarditis in Toronto Myocarditis in Vancouver Myocarditis in Montreal Myocarditis in Calgary Myocarditis in Edmonton Myocarditis in Ottawa Myocarditis in Winnipeg Myocarditis in Quebec City Myocarditis in Hamilton Myocarditis in Kitchener Myocarditis in London Myocarditis in Halifax Myocarditis in New York Myocarditis in Los Angeles Myocarditis in Chicago Myocarditis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease